How long do I have to live with HER2-Positive Breast Cancer
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Understanding HER2-Positive Breast Cancer Prognosis
I understand this is one of the most important questions you're facing. Let me be direct: I cannot and should not give you a specific survival estimate. Here's why, and what the evidence actually shows:
Why Prognosis Is Individual, Not Universal
Your specific survival depends on many factors that are unique to YOU:
- Stage at diagnosis (early vs. advanced)
- Your age and overall health
- How your tumor responds to treatment
- Which specific treatments you receive
- Genetic factors and tumor biology
- Access to newer therapies
No two HER2-positive breast cancers are identical, even if they look similar under a microscope.
What the Evidence Shows About HER2-Positive Breast Cancer
The good news: HER2-positive breast cancer has dramatically improved outcomes compared to 10-20 years ago.
According to the webinar "Clinical Guidance from Proteomics" (Sheeno Thyparambil), research shows that patients with high HER2 expression who received anti-HER2 therapy had "no events at all" when followed for 6-7 years. This represents a significant shift in how we treat this cancer type.
Key Points About HER2-Positive Breast Cancer:
Anti-HER2 therapies work. The evidence shows that:
- Dual anti-HER2 therapy (combining drugs like pertuzumab and trastuzumab) can produce "vast improvement in outcomes"
- Newer antibody-drug conjugates like trastuzumab deruxtecan (Enhertu) are showing strong results
- Treatment options continue to expand
Even "HER2-low" cancers now have options. Historically, only HER2 3+ cancers (highest expression) were treated with anti-HER2 drugs. Now, patients with lower HER2 levels have access to newer therapies that weren't available years ago.
What You Should Do Now
Rather than focusing on survival statistics, focus on actionable next steps:
Questions to ask your oncologist:
- What is my specific stage and HER2 expression level? (This matters enormously)
- What treatment plan do you recommend, and why? (Different stages get different approaches)
- Are there clinical trials I'm eligible for? (Newer options may be available)
- How will we monitor my response to treatment? (This helps adjust if needed)
- What support services are available? (Mental health, nutrition, survivorship planning)
The Bottom Line
The trajectory for HER2-positive breast cancer has changed dramatically. Many patients live well beyond initial diagnoses, especially with:
- Early detection
- Modern anti-HER2 therapies
- Access to newer treatment options
- Good medical care and support
Your oncologist, who knows your complete medical picture, is the only person who can discuss YOUR specific situation and prognosis.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Invasive Breast Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with diagnosis for HER2-Positive Breast Cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: